Advertisement

HNO

pp 1–4 | Cite as

Vestibular migraine treatment and prevention

  • A. LapiraEmail author
Leitthema
  • 95 Downloads

Abstract

Vestibular migraine probably represents the second most common cause of vertigo after benign positional vertigo, by far exceeding Ménière disease. There are still relatively few published reports on vestibular migraine management, despite its enormous importance in daily practice. In 2003 the first clinical definition of vestibular migraine was proposed. Studies published before 2003 used variable terms for vestibular migraine. Some authors recommend treating vestibular migraine using multiple drugs; others have focused on using only one drug. Although at present it is not possible to quantify the effects of the treatments proposed, some recommendations can be made.

Keywords

Migraine disorders Vertigo Episodic vertigo Pharmacotherapy Vestibular apparatus 

Behandlung und Prävention von vestibulärer Migräne

Zusammenfassung

Die vestibuläre Migräne ist wahrscheinlich die zweithäufigste Ursache für Schwindel nach dem gutartigen positionellen Schwindel, der die Menière-Krankheit bei Weitem übersteigt. Es gibt bisher nur wenige veröffentlichte Berichte über die Behandlung der vestibulären Migräne, trotz ihrer enormen Bedeutung für die tägliche Praxis. Im Jahr 2003 wurde die erste klinische Definition der vestibulären Migräne vorgeschlagen. Vor 2003 veröffentlichte Studien verwendeten variable Begriffe für vestibuläre Migräne. Einige Autoren empfehlen die Behandlung der vestibulären Migräne mit mehreren Medikamenten, andere haben sich auf die Verwendung nur eines Medikaments konzentriert. Derzeit ist es zwar nicht möglich, die Auswirkungen der vorgeschlagenen Behandlungen zu quantifizieren, aber es können einige Empfehlungen ausgesprochen werden.

Schlüsselwörter

Migräneerkrankungen Schwindel Episodischer Schwindel Pharmakotherapie Vestibularapparat 

Notes

Compliance with ethical guidelines

Conflict of interest

A. Lapira declares that he has no competing interests.

For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.

References

  1. 1.
    Lempert T, Neuhauser H (2009) Epidemiology of vertigo, migraine and vestibular vertigo. J Neurol 256:333–338CrossRefGoogle Scholar
  2. 2.
    Furman JM, Marcus DA, Balaban CD (2003) Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview. Curr Opin Neurol 16:5–13CrossRefGoogle Scholar
  3. 3.
    Ménière P (1861) Memoire sur des lesions de loreille interne donnant lieu a des symptomes de congestion cerebrale apoplectiforme. Gaz Med 16:597–601Google Scholar
  4. 4.
    Symonds CP (1926) Vertigo. J Postgrad Med 1:63–66CrossRefGoogle Scholar
  5. 5.
    Graham JR (1968) Migraine: clinical aspects. In: Vinken PJ, Bruin GW (eds) Handbook of clinical neurology, 1st edn. North-Holland, Amsterdam, pp 45–58Google Scholar
  6. 6.
    Kayan A, Hood JD (1984) Neuro-otological manifestations of migraine. Brain 107:1123–1142CrossRefGoogle Scholar
  7. 7.
    Neuhauser HK, Radtke A, von Brevern M et al (2006) Migrainous vertigo: prevalence and impact on quality of life. Baillieres Clin Neurol 67(6):1028–1033Google Scholar
  8. 8.
    Cutrer FM, Baloh RW (1992) Migraine-associated dizziness. Headache 32:300–304CrossRefGoogle Scholar
  9. 9.
    Vukovic V, Plavec D, Galinovic I, Lovrencic-Huzja A, Budisic M, Demarin V (2007) Prevalence of vertigo, dizziness, and migrainous vertigo in patients with migraine. Headache 47:1427–1435CrossRefGoogle Scholar
  10. 10.
    Neuhauser H, Lempert T (2004) Vertigo and dizziness related to migraine: a diagnostic challenge. Cephalgia 24:83–91CrossRefGoogle Scholar
  11. 11.
    von Brevern M, Zeise D, Neuhauser H, Clarke AH, Lempert T (2005) Acute migrainous vertigo: clinical and oculographic findings. Brain 128:365–374CrossRefGoogle Scholar
  12. 12.
    Baloh RW (1997) Neurotology of migraine. Headache 37:615–621CrossRefGoogle Scholar
  13. 13.
    Vincent M, Hadjikhani N (2007) The cerebellum and migraine. Headache 47:820–833CrossRefGoogle Scholar
  14. 14.
    Goadsby PJ (2009) The vascular theory of migraine—a great story wrecked by the facts. Brain 132:6–7CrossRefGoogle Scholar
  15. 15.
    Russo A, Marcelli V, Esposito F et al (2014) Abnormal thalamic function in patients with vestibular migraine. Baillieres Clin Neurol 82(23):2120–2126Google Scholar
  16. 16.
    Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR (2009) Neurobiology of migraine. Neuroscience 161:327–341CrossRefGoogle Scholar
  17. 17.
    Jen J, Kim GW, Baloh RW (2004) Clinical spectrum of episodic ataxia type 2. Baillieres Clin Neurol 62:17–22Google Scholar
  18. 18.
    Lee H, Jen JC, Wang H et al (2006) A genome-wide linkage scan of familial benign recurrent vertigo: linkage to 22q12 with evidence of heterogeneity. Hum Mol Genet 15(2):251–258CrossRefGoogle Scholar
  19. 19.
    Lee H, Sininger L, Jen JC et al (2007) Association of progesterone receptor with migraine-associated vertigo. Neurogenetics 8(3):195–200CrossRefGoogle Scholar
  20. 20.
    Furman JM, Marcus DA, Balaban CD (2013) Vestibular migraine: clinical aspects and pathophysiology. Lancet Neurol 12(7):706–715CrossRefGoogle Scholar
  21. 21.
    Neuhauser H, Leopold HM, von Brevern M, Arnold G, Lempert T (2001) The interrelations of migraine, vertigo, and migrainous vertigo. Baillieres Clin Neurol 56:436–441Google Scholar
  22. 22.
    International Headache Soxiety (2018) The international classification of headache disorders, 3rd edition [beta version]. Cephalgia 38(1):1–211CrossRefGoogle Scholar
  23. 23.
    Olsson JE (1991) Neurotologic findings in basilar migraine. Laryngoscope 101(Suppl 52):1–41CrossRefGoogle Scholar
  24. 24.
    Celebisoy N, Gokcay F, Sirin H et al (2008) Migrainous vertigo: clincal, oculographic and posturographic findings. Cephalgia 28(1):72–77CrossRefGoogle Scholar
  25. 25.
    Rang HP, Dale MM, Ritter JM, Moore PK (2003) Pharmacology. Elsevier, BathGoogle Scholar
  26. 26.
    Tusa RJ (1999) Diagnosis and management of neuro-otological disorders due to migraine. In: Herdmann SJ (ed) Vestibular rehabilitation. FA Davis, Philadelphia, pp 298–315Google Scholar
  27. 27.
    Olesen J (1988) Calcium entry blockers in the treatment of vertigo. Ann N Y Acad Sci 522:690–697CrossRefGoogle Scholar
  28. 28.
    Reploeg MD, Goebel JA (2002) Migraine-associated dizziness: Patient characteristics and management options. Otol Neurotol 23:364–371CrossRefGoogle Scholar
  29. 29.
    Ramadan NM (2007) Current trends in migraine prophylaxis. Headache 47(Suppl 1):S52–S57CrossRefGoogle Scholar
  30. 30.
    Furman JM, Balaban CD, Jacob RG, Marcus DA (2005) Migraine–anxiety related dizziness (MARD): a new disorder? J Neurol Neurosurg Psychiatry 76:1–8CrossRefGoogle Scholar
  31. 31.
    Albera R, Ciuffolotti R, Di Cicco M, De Benedittis G, Grazioli I, Melzi G et al (2003) Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo. Acta Otolaryngol 123:588–593CrossRefGoogle Scholar
  32. 32.
    Fraysse B, Bebear JP, Dubreuil C, Berges C, Dauman R (1991) Betahistine dihydrochloride versus flunarizine. A double-blind study on recurrent vertigo with or without cochlear syndrome typical of Menière’s disease. Acta Otolaryngol Suppl 490:1–10CrossRefGoogle Scholar
  33. 33.
    Vahedi K, Taupin P, Djomby R, El-Amrani M, Lutz G, Filipetti V et al (2002) Efficacy and tolerability of acetazolamide in migraine prophylaxis: A randomised placebo-controlled trial. J Neurol 249:206–211CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.St James & Capua HospitalsSliemaMalta
  2. 2.University of MaltaMsidaMalta
  3. 3.Nova Southeastern UniversityFort LauderdaleUSA

Personalised recommendations